テラハラ アツロウ
Terahara Atsuro
寺原 敦朗 所属 東邦大学 医学部 医学科(大森病院) 職種 教授 |
|
論文種別 | 原著 |
言語種別 | 英語 |
査読の有無 | 査読あり |
表題 | Long-term outcomes of stereotactic radiosurgery for arteriovenous malformations in the thalamus. |
掲載誌名 | 正式名:Neurosurgery 略 称:Neurosurgery ISSNコード:0148396X/15244040 |
巻・号・頁 | 67(2),pp.398-403 |
著者・共著者 | Koga T, Shin M, Maruyama K, Terahara A†, Saito N |
発行年月 | 2010/08 |
概要 | BACKGROUND: Arteriovenous malformations (AVMs) in the thalamus carry a high risk of hemorrhage. Although stereotactic radiosurgery (SRS) is widely accepted because of the high surgical morbidity and mortality of these lesions, precise long-term outcomes are largely unknown. OBJECTIVE: To review our experience with SRS for thalamic AVMs based on the latest follow-up data. METHODS: Forty-eight patients with thalamic AVMs were treated by SRS using the Leksell Gamma Knife and were followed. Long-term outcomes including the obliteration rate, hemorrhage after treatment, and adverse effects were retrospectively analyzed. RESULTS: The annual hemorrhage rate before SRS was 14%. The mean follow-up period after SRS was 66 months (range 6-198 months). The actuarial obliteration rate confirmed by angiography was 82% at 5 years after treatment, and the annual hemorrhage rate after SRS was 0.36%. Factors associated with higher obliteration rates were previous hemorrhage (P = .004) and treatment using new planning software (P = .001). Persistent worsening of neurological symptoms was observed in 17% and more frequently seen in patients who were treated using older planning software (P = .04) and a higher margin dose (P = .02). The morbidity rate for patients who received treatment planned using new software with a margin dose not more than 20 Gy was 12%. CONCLUSION: SRS for thalamic AVMs achieved a high obliteration rate and effectively decreased the risk of hemorrhage, with less morbidity compared with other modalities. Longer follow-up to evaluate the risk of delayed complications and the effort to minimize the morbidity is necessary. |
DOI | 10.1227/01.NEU.0000371989.90956.6F |